• Tuberculosis and Respiratory Diseases
• /
• 제79권2호
• /
• pp.74-84
• /
• 2016

Nontuberculous mycobacteria (NTM) are emerging pathogens that affect both immunocompromised and immunocompetent patients. The incidence and prevalence of NTM lung disease are increasing worldwide and rapidly becoming a major public health problem. For the diagnosis of NTM lung disease, patients suspected to have NTM lung disease are required to meet all clinical and microbiologic criteria. The development of molecular methods allows the characterization of new species and NTM identification at a subspecies level. Even after the identification of NTM species from respiratory specimens, clinicians should consider the clinical significance of such findings. Besides the limited options, treatment is lengthy and varies by species, and therefore a challenge. Treatment may be complicated by potential toxicity with discouraging outcomes. The decision to start treatment for NTM lung disease is not easy and requires careful individualized analysis of risks and benefits. Clinicians should be alert to those unique aspects of NTM lung disease concerning diagnosis with advanced molecular methods and treatment with limited options. Current recommendations and recent advances for diagnosis and treatment of NTM lung disease are summarized in this article.

• KSII Transactions on Internet and Information Systems (TIIS)
• /
• 제18권2호
• /
• pp.284-310
• /
• 2024

Identifying clinical pathways for disease diagnosis and treatment process recommendations are seriously decision-intensive tasks for health care practitioners. It requires them to rely on their expertise and experience to analyze various categories of health parameters from a health record to arrive at a decision in order to provide an accurate diagnosis and treatment recommendations to the end user (patient). Technological adaptation in the area of medical diagnosis using AI is dispensable; using expert systems to assist health care practitioners in decision-making is becoming increasingly popular. Our work architects a novel knowledge-based recommender system model, an expert system that can bring adaptability and transparency in usage, provide in-depth analysis of a patient's medical record, and prescribe diagnostic results and treatment process recommendations to them. The proposed system uses a set of parallel discrete fuzzy rule-based classifier systems, with each of them providing recommended sub-outcomes of discrete medical conditions. A novel knowledge-based combiner unit extracts significant relationships between the sub-outcomes of discrete fuzzy rule-based classifier systems to provide holistic outcomes and solutions for clinical decision support. The work establishes a model to address disease diagnosis and treatment recommendations for primary lung disease issues. In this paper, we provide some samples to demonstrate the usage of the system, and the results from the system show excellent correlation with expert assessments.

• 대한의생명과학회지
• /
• 제21권1호
• /
• pp.1-8
• /
• 2015

Alzheimer's disease is a common form of dementia occurring among the elderly population and can be identified by symptoms such as cognition impairments, memory loss and neuronal dysfunction. Alzheimer's disease was found to be caused by the deposition of $\beta$-amyloid plaques and neurofibrillary tangles. In addition, mutation in the APP (Amyloid precursor protein), Presenilin 1 (PSEN1) and Presenilin 2 (PSEN2) genes were also found to contribute to Alzheimer's disease. Since the potential conformational diagnosis of Alzheimer's disease requires histopathological tests on brain through autopsy, potential early diagnosis still remains challenging. In recent years, several researches have proposed the use of biomarkers for early diagnosis. In cerebrospinal fluid (CSF), $\beta$-amyloid(1-42), phosphorylated-tau and total tau were suggested to be effective biomarkers for Alzheimer's disease diagnosis. However, a single biomarker might not be sufficient for potential diagnosis of Alzheimer's disease. Thus, the use of RNA interference (RNAi) through microRNAs (miRNAs) has been proposed by several researchers for simultaneous analysis of several biomarkers using microarray technology. These miRNA based biomarkers can be analysed from both blood and CSF, but miRNAs from blood are advantageous over CSF as they are non-invasive and simple for collection. Moreover, the RNAi based therapeutics by siRNA (short interference RNA) or shRNA (short hairpin RNA) have also been proposed to be effective in the treatment of Alzheimer's disease. This review describes the promising application of RNAi technology in therapeutics and as a biomarker for both Alzheimer's disease diagnosis and treatment.

• 보건의료산업학회지
• /
• 제5권4호
• /
• pp.1-13
• /
• 2011

The purpose of this study is to analyze the medical care utilization behavior of patients to whom treatment (surgery) is recommended after they are diagnosed with abnormal findings on health screening and factors affecting the selection of the medical institute for treatment. The data was collected from 291 patients who need treatment or surgery, according to the abnormal findings on the additional examination such as cardiac CT, brain MRI, Gastroscopy and Colonoscopy since four diseases are suspected among of 2,752 people who receive health screening. The results are as follows. First, the most common disease of patients who have abnormal findings by the diagnosis through the results of first testing is colon disease based on through the additional examination. The most common disease of patients who will get treatment (surgery) based on final diagnosis by a doctor who determines the result of health screening on the basis of diagnosis from the first testing is cardiovascular disease. Second, in terms of diseases, patients with cardiovascular disease select the medical institute where they get the health screenings as a place for treatment. Patients with cerebrovascular disease select another medical institute for treatment. Finally, the affective factors of selectivity treatment facility on health screening satisfaction were human, facility, health screening and revisit factors.

• 제3의학
• /
• 제1권1호
• /
• pp.57-89
• /
• 1996

A Typification of diagnosis and treatment(DT) model must be done in order to generalize the objective stage to the result of treatment to internal disease in connection with the type of viscera and bowel symptom. We could find 108 DT models in internal disease from the combination of 18 types of viscera and bowel and 6 types of DT treatment processes. Thus, the typification of 108 models of DT can be viewed as a modeling processes of utilizing DT knowledge at each stage. We argue that objectivity in diagnosis and treatment of internal disease can be obtained practically from typification of DT model.

• 동의생리병리학회지
• /
• 제25권5호
• /
• pp.790-798
• /
• 2011

'Mu-acupuncture treatment(繆刺法)' and 'Geo-acupuncture treatment(巨刺法)' are the ways of taking acupuncture points on the sound side of a human body and not on the unsound side of a human body to treat disease, 'Mu-acupuncture treatment(繆刺法)' is applicable to 'Transverse meridian disease(絡脈病)', 'Geo-acupuncture treatment(巨刺法)' is applicable to 'Longitudinal meridian disease(經脈病)'. To diagnose a disease as transverse meridian disease or longitudinal meridian disease depends on 'Feeling pulse at the nine spots of three parts on a body for diagnosis (三部九候診)'. 'Mu-acupuncture treatment(繆刺法)' takes a 'Rak-acupuncture point(絡穴)' under a wrist and a ankle joint. The method of taking it, two ways, are 'Yu(痏)' and 'The treatment getting some blood(出血療法)'. 'Yu(?)' which is similar to 'Quick-getting acupuncture into and out (單刺法)' means the number of times doing acupuncture and is different from 'The treatment getting some blood (出血療法)' which is typically considered as 'Yu(?)'. Meanwhile, judging from the changes of the methods of feeling pulse for diagnosis and the symptoms of a certain disease, though it is a precondition that 'Biased-Gi(邪氣)' stays at 'The Large transverse meridian(大絡)' in 'The theory of Mu-acupuncture treatment(繆刺論)', it is hard to consider the symptoms of 'Transverse meridian disease(絡脈病)' described in 'The theory of Mu-acupuncture treatment(繆刺論)' as the pure symptoms of 'Transverse meridian disease(絡脈病)'.

• Journal of Acupuncture Research
• /
• 제21권1호
• /
• pp.21-32
• /
• 2004

Objective: A study on $\ll$Lingchui, 靈樞 Weiqi, 衛氣$\gg$ which descripted Twelve meridian Biaoben(標本) pulse diagnosis method. Methods: A study on Twelve meridian Biaoben(標本) pulse diagnosis method which has the cognizance of Biaoben(標本) on upper and low twelve meridian as linear upper and low pulse diagnosis point. Results: Twelve meridian Biaoben(標本) pulse diagnosis method is derived from using each twelve meridian pulse diagnosis and it can be explained that the ben(本) pulse point on wrist ankle and the biao(標) pulse point on thorax axillary neck head face correspond to upper and low part of meridian for diagnosis and treatment which become the theory of "treat upper disease on low part, treat low disease on upper part". Conclusions: Twelve meridian Biaoben(標本) pulse diagnosis method started confirming the general concept of Jue-symptom(厥症) and Jue-symptom(絶症) and developed upper and low pulse diagnosis point or acupuncture point to treatment.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제16권4호
• /
• pp.225-232
• /
• 2013

Children with abnormal liver function can often be seen in outpatient clinics or inpatients wards. Most of them have respiratory disease, or gastroenteritis by virus infection, accompanying fever. Occasionally, hepatitis by the viruses causing systemic infection may occur, and screening tests are required. In patients with jaundice, the tests for differential diagnosis and appropriate treatment are important. In the case of a child with hepatitis B virus infection vertically from a hepatitis B surface antigen positive mother, the importance of the recognition of immune clearance can't be overstressed, for the decision of time to begin treatment. Early diagnosis changes the fate of a child with Wilson disease. So, screening test for the disease should not be omitted. Non-alcoholic fatty liver disease, which is mainly discovered in obese children, is a new strong candidate triggering abnormal liver function. Muscular dystrophy is a representative disease mimicking liver dysfunction. Although muscular dystrophy is a progressive disorder, and early diagnosis can't change the fate of patients, it will be better to avoid parent's blame for delayed diagnosis.

• 대한한의진단학회지
• /
• 제16권1호
• /
• pp.35-44
• /
• 2012

Objectives The purpose of this study is to report the effect of oriental demonstration treatment for episodic vertigo of Meniere's disease. Meniere's Disease characterized by recurrent prostrating episodic vertigo, nausea, vomiting, sensory hearing loss, tinnitus, and a feeling of fullness in the ear associated with generalized dilation of the membranous labyrinth (endolymphatic hydrops). The cause of Meniere's disease is unknown, and the pathophysiology is poorly understood. Methods We experienced one case of Meniere's disease treated with Asian medical treatment, acupuncture and herbal medication. 64-year-old female patient was diagnosed with Meniere's disease by western medical doctor. Methods: Saam acupuncture Sojangjungkyuk applied to the patient. Results After treatment her episodic vertigo, nausea, vomiting and endolymphatic hydrops were decreased but the level of tinnitus it was not improved as much as other symptoms. Conclusions Saam Acupuncture of Asian medical treatment could be safe and effective.

• Clinical and Experimental Pediatrics
• /
• 제49권11호
• /
• pp.1152-1157
• /
• 2006

Inherited metabolic disease is rare disorders that show symptoms mainly in pediatric age and early treatment is important for preventing complications of the disease. Recent development in molecular and biochemical techniques help clinicians with proper diagnosis of patients, however, many of the disease still remain lack of effective therapeutic strategies. Better understanding on biochemical and molecular basis of pathogenesis of the disease combined with advanced medical care would provide new sight on the disease that can also improve the quality of life and long-term prognosis of patients. Traditionally, there are several modalities in the treatment of metabolic diseases depend on the biochemical basis of the disease such as diet restriction, removing or blocking the production of toxic metabolites, and stimulating residual enzyme activity. The inherited metabolic disease is not familiar for many clinicians because the diagnosis is troublesome, treatment is complicated and prognosis may not as good as expected in other diseases. Recently, new therapeutic regimens have been introduced that can significantly improve the medical care of patients with metabolic disease. Enzyme replacement therapy has showed promising efficacy for lysosomal storage disease, bone marrow transplantation is effective in some disease and gene therapy has been trying for different diseases. The new trials for treatment of the disease will give us promising insight on the disease and most clinicians should have more interest in medical progress of the metabolic disease.